What's New

Last Posted: Feb 25, 2020

• Myasthenia gravis and azathioprine treatment: Adverse events related to thiopurine S-methyl-transferase (TPMT) polymorphisms.
  Lorenzoni Paulo José, et al. Journal of the neurological sciences 2020 2 116734
• The associations of HLA-DRB1 gene polymorphisms with late-onset myasthenia gravis: a meta-analysis.
  Ling Cai-Se, et al. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2020 1
• Associations of BAFF rs2893321 polymorphisms with myasthenia gravis susceptibility.
  Deng Hui, et al. BMC medical genetics 2019 10 (1) 168
• Association between CTLA-4 gene polymorphism and myasthenia gravis in a Chinese cohort.
  Cai Gao-Mei, et al. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2019 8
• Association of early onset myasthenia gravis in Newfoundland dogs with the canine major histocompatibility complex class I.
  Wolf Zena, et al. Neuromuscular disorders : NMD 2017 5 (5) 409-416
• Exome sequencing identifies targets in the treatment-resistant ophthalmoplegic subphenotype of myasthenia gravis.
  Nel Melissa, et al. Neuromuscular disorders : NMD 2017 9 (9) 816-825
• Novel genetic loci associated HLA-B*08:01 positive myasthenia gravis.
  Varade Jezabel, et al. Journal of autoimmunity 2018 0 43-49
• Rs3761389 polymorphism in autoimmune regulator (AIRE) gene is associated with susceptibility of myasthenia gravis in Chinese patients.
  Zhang Xu, et al. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2017 6 180-184
• A Natural Variant of the Signaling Molecule Vav1 Enhances Susceptibility to Myasthenia Gravis and Influences the T Cell Receptor Repertoire.
  Bernard Isabelle, et al. Frontiers in immunology 2018 0 2399
• HLA and MuSK-positive myasthenia gravis: A systemic review and meta-analysis.
  Hong Y, et al. Acta neurologica Scandinavica 2018 9 (3) 219-226
• Gene Polymorphisms for Both Auto-antigen and Immune-Modulating Proteins Are Associated with the Susceptibility of Autoimmune Myasthenia Gravis.
  Li Hai-Feng, et al. Molecular neurobiology 2017 0 (6) 4771-4780
• ß2-Adrenergic receptor gene polymorphisms in the relapse of myasthenia gravis with thymus abnormality.
  Wang Lili, et al. The International journal of neuroscience 2017 4 (4) 291-298
• Association of PTPN22 1858C/T Polymorphism with Autoimmune Diseases: A Systematic Review and Bayesian Approach.
  Tizaoui Kalthoum, et al. Journal of clinical medicine 2019 3 (3)
• IL-2 gene polymorphisms affect tacrolimus response in myasthenia gravis.
  Shumei Yang, et al. European journal of clinical pharmacology 2019 2
• Association of CTLA-4 polymorphisms with increased risks of myasthenia gravis.
  Li Fang, et al. Annals of human genetics 2018 11 (6) 358-369